Copyright © 2026 VPM, all rights reserved.
PBS is a 501(c)(3) not-for-profit organization.
VPM News Morning Edition
NEXT UP: 9:00 AM

Thanks to our sponsors – Become a Sponsor

Spike In Coronavirus Cases Overwhelms Testing Labs Across The U.S.

AILSA CHANG, HOST:

With the surge in new coronavirus cases in the U.S., demand for testing has also risen sharply, and labs are falling behind. Quest Diagnostics, one of the nation’s largest testing companies, says it now has a turnaround time of four to six days to run a test for someone who is not in a hospital. Long lines are forming at testing sites from Denver to New Orleans, and that delay means infected people may be spreading the disease for days without even knowing it. Joining us for the latest on this is NPR science correspondent Richard Harris.

Hey, Richard.

RICHARD HARRIS, BYLINE: Hi, Ailsa.

CHANG: Hi. I mean, testing has been a struggle since the earliest days of the coronavirus. So where exactly do we stand now?

HARRIS: Federal officials boast about the sheer numbers of tests that are getting done. It’s now more than 600,000 on an average day, which is certainly a big step up from a few months ago. But…

CHANG: Sure.

HARRIS: …That’s straining the capacity of the system. And when you consider that public health officials say they need a lot more testing in order to really get ahead of the epidemic, it really shows how much more work there is to go.

CHANG: And is it simply that the huge demand is creating these problems?

HARRIS: That appears to be the major driving factor. But you know, there are still problems with supplies. Yesterday in a telephone briefing, Admiral Brett Giroir from the White House coronavirus task force said from the federal perspective, the supply system is working.

(SOUNDBITE OF ARCHIVED RECORDING)

BRETT GIROIR: The states are getting all the upstream supplies that they asked for – so tubes, the media, swabs. Basically, they put in their order to the federal government. They get it delivered to a single site every week within the states. And we are meeting everything that they’re asking for.

CHANG: We are meeting everything. Well, is that what you’re hearing from labs?

HARRIS: Well, there seems to be a breakdown somewhere because I talked to Mark Birenbaum, who’s the executive director of the National Independent Laboratory Association. This represents community and regional labs. And he says those labs still don’t have reliable supplies.

MARK BIRENBAUM: We’ve had trouble identifying who has those supplies in each state and how our labs can access that, how it’s being allocated. We asked the task force to give us the name of each state contact that the supplies were sent to, and we can’t get that list.

HARRIS: And Birenbaum told me that some labs could actually run more tests, but they aren’t getting enough samples to run. Others need particular ingredients that may or may not be available, depending upon the day. In New Orleans, for example, testing is constrained because the city can’t get supplies to run the specific testing machine that they use.

CHANG: I mean, obviously, these testing delays are frustrating to people who have to wait for hours in line and then have to wait many days to get their results. Can you just talk about the health risks of all of that?

HARRIS: Right. One of the biggest concerns is that people are often most infectious just in the first few days before symptoms appear. So if they’ve gone to go get a test after learning that they’ve been in close contact with somebody who has COVID-19, by the time they get their results, it’s really too late. Here’s Alison Galvani at the Yale School of Public Health.

ALISON GALVANI: You will have missed your window of opportunity to curtail their transmission. It makes it much more challenging to control the disease. It’s a gap that we need to close in order to bring this disease under control.

HARRIS: And Galvani and her colleagues have just published a rather sobering paper showing that it really won’t be possible to control the epidemic simply by isolating people who are already showing symptoms. Health officials really need to do rapid contact tracing and rapid testing to find cases as early as possible, and that’s just really not happening right now in a lot of places.

CHANG: That is NPR’s Richard Harris.

Thank you, Richard.

HARRIS: Pleased to be with you.

(SOUNDBITE OF CITY OF THE SUN’S “VENTURA”) Transcript provided by NPR, Copyright NPR.

NPR transcripts are created on a rush deadline by an NPR contractor. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Tags

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.

In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington Star in DC.

Harris is co-founder of the Washington, DC, Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

Harris' book Rigor Mortis was published in 2017. The book covers the biomedicine "reproducibility crisis" — many studies can't be reproduced in other labs, often due to lack of rigor, hence the book's title. Rigor Mortis was a finalist for the 2018 National Academy of Sciences/Keck Communication Award.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Related Stories